Retractable Technologies Inc (RVP): RVP hit $10.48 today. Profit takers too...

RVP hit $10.48 today. Profit takers took

JJSeabrook · 2020-07-16T20:18:51.9500000Z

RVP hit $10.48 today. Profit takers took it down some at the end but she set a new high today!

Play Episode

5min

Proactive - Interviews for investors

Europa Oil & Gas CEO on Cloughton planning application and community engagement

Europa Oil & Gas (Holdings) Plc (AIM:EOG) CEO Will Holland talked with Proactive's Stephen Gunnion about the company's submission of a planning application for the Cloughton appraisal well in Yorkshire. The application seeks approval to drill and test a gas field originally discovered in 1986. Holland explained that advancements in technology and improved gas prices now make it viable to extract gas at commercial rates. The appraisal well will determine the feasibility of full-field development. He also discussed the launch of a dedicated community engagement website, designed to provide local stakeholders with transparent information, including independent environmental and regulatory reports. Holland emphasised that the project follows strict UK regulations and aims to minimise environmental impact. Addressing concerns, he clarified that fracking is not involved, citing confirmation from Energy Minister Michael Shanks. He also noted that increased heavy goods vehicle (HGV) traffic would be minimal, at around 1% during operations. Holland stressed the project's potential benefits, including job creation and reducing the UK's reliance on imported liquefied natural gas (LNG). “If you're concerned about the environment, you should be supporting domestic gas production. And that's exactly what this is,” he stated. For more interviews with industry leaders, visit Proactive’s YouTube channel. Don't forget to like this video, subscribe, and turn on notifications for updates! #EuropaOilAndGas #EnergySecurity #NaturalGas #UKGas #CloughtonWell #EnergyTransition #Investing #OilAndGas #SustainableEnergy #LNG

Proactive - Interviews for investors

Clinical study SKNJCT-003 shows positive trends as company advances skin cancer research in UAE

Medicus Pharma CEO Dr. Raza Bokhari joined Steve Darling from Proactive to share updates on the ongoing SKNJCT-003 clinical study, which is being conducted at nine sites across the United States and aims to randomize 60 patients. An interim analysis conducted after enrolling more than half of the targeted participants has shown encouraging results. The study reports a clinical clearance rate exceeding 60%, with the investigational therapy demonstrating strong tolerability across both tested dosage levels. Notably, no dose-limiting toxicities (DLTs) or serious adverse events (SAEs) have been observed, and there have been no systemic effects or clinically significant abnormalities in laboratory results, ECGs, vital signs, or physical exams. These promising findings will be submitted to the U.S. Food and Drug Administration (FDA) as part of a Type C meeting request in Q2 2025. In parallel, the company is advancing its clinical initiatives for non-invasive basal cell carcinoma treatment with a newly proposed study. This randomized, double-blind, placebo-controlled, multi-center trial has been submitted for approval to the UAE Department of Health. The study aims to enroll up to 36 patients at prominent medical institutions, including Cleveland Clinic Abu Dhabi, Sheikh Shakbout Medical City, Burjeel Medical City, and the American Hospital of Dubai. Participants will be assigned in a 1:1:1 ratio to receive either a placebo or one of two dosage levels of the experimental treatment. This expansion into the UAE represents a significant step forward in the company’s mission to develop innovative, non-invasive therapies for skin cancer, broadening its global clinical footprint and reinforcing its commitment to advancing patient care. #proactiveinvestors #nasdaq #mdcx #tsxv #mdcx #pharma #Biotech #CancerTreatment #ClinicalTrials #FDAApproval #SkinCancer #HealthcareInnovation #Investing #MedicalResearch

Proactive - Interviews for investors

Graphene Manufacturing Group advances aluminium-ion battery development with key U.S. partnership

Graphene Manufacturing Group CEO Craig Nicol joined Steve Darling from Proactive to share an update as the company continues to make strides in the development of its Graphene Aluminium-Ion Battery technology, a cutting-edge innovation being pursued in collaboration with the University of Queensland and Rio Tinto under a Joint Development Agreement. Nicol told Proactive, to accelerate battery development, GMG has signed a service contract with the Battery Innovation Center (BIC) in Indiana, USA. This partnership will support the next phase of research and optimization, leveraging BIC’s state-of-the-art 40,000-square-foot facility in Newberry, Indiana. As a globally recognized innovation hub, BIC specializes in advancing battery technologies, offering end-to-end support from research and development to prototype manufacturing and low-volume production—a critical advantage for GMG as it scales up its graphene-based energy storage solutions. Nicol emphasized that collaborating with BIC allows GMG to access advanced battery manufacturing infrastructure without incurring the high capital costs of building its own pilot production facility—an investment that could exceed AU$10 million. Through this agreement, GMG will retain full intellectual property (IP) rights over the battery development work, ensuring control over its proprietary technology while optimizing BIC’s cell design expertise and battery manufacturing capabilities. By integrating BIC’s expertise into its scale-up strategy, GMG can streamline the production of sample battery cells before committing to mass production, reducing risks and deferring large capital expenditures until the technology reaches a higher level of readiness. Looking ahead, GMG aims to optimize battery performance, produce initial test cells this year, and engage customers for validation. Nicol noted strong interest from major companies eager to integrate this technology. #proactiveinvestors #graphenemanufacturinggroupltd #BatteryTech #

Proactive - Interviews for investors

Frontier IP investee GraphEnergyTech discusses solar panel collaboration

GraphEnergyTech CEO Dr Thomas Baumeler discussed a collaboration with the Taiwan Perovskite Solar Corporation, Taiwan’s prestigious Industrial Technology Research Institute and the University of Cambridge. The project is supported by an Innovate UK grant worth nearly £900,000. Known as GETPSC (Graphene Electrode Technology for Perovskite Solar Cells), Baumeler explained that current solar cells rely on expensive silver electrodes, which degrade when in contact with Perovskite Solar Cells. GraphEnergyTech, a Frontier IP Group PLC (AIM:FIPP) portfolio company, aims to replace these with graphene-based electrodes, offering a more stable and cost-effective alternative. "Graphene is one of the most interesting materials out there," he said, highlighting its durability and lower cost compared to silver. Perovskite Solar Cells are considered the next major advancement in photovoltaics due to their efficiency and simpler manufacturing process. However, industrial-scale adoption has been hindered by the lack of a viable nonmetallic electrode—something GraphEnergyTech aims to solve. Baumeler also noted that GraphEnergyTech is working on replacing silver electrodes in traditional silicon-based solar cells while exploring applications for its conductive carbon-based technology in batteries, supercapacitors, and electronics. For more insights into renewable energy innovations, visit Proactive’s YouTube channel. Don’t forget to like this video, subscribe, and enable notifications for future updates. #GraphEnergyTech #SolarEnergy #GrapheneTech #PerovskiteSolar #RenewableEnergy #CleanEnergy #TechInnovation #SolarCells #GreenTechnology #EnergyStorage

Followers	763
Posts	43017
Boards Moderated	2
Alias Born	03/11/2004

Volume:	50,415
Day Range:	0.72 - 0.7751
Bid:
Ask:
Last Trade Time:	7:17:25 PM EDT
Total Trades:	175

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

RVP Detailed Quote

Recent RVP News

More RVP News

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Discover

Boards:

Quotes:

Recent RVP News

Go Ad-Free